RecallDepth
Class II Ongoing

Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/320 mg/25 mg, (a) 30-count bottles (NDC 0093-7809-56) & 90-count bottles (NDC 0093-7809-98), RX Only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel, Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.

This recall is currently active, issued December 19, 2018. It was issued by Teva Pharmaceuticals Usa.

Company
Teva Pharmaceuticals Usa
Recall Initiated
November 27, 2018
Posted
December 19, 2018
Recall Number
D-0310-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
31,079 bottles
Firm Location
North Wales, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.

Distribution

USA Nationwide including Puerto Rico.

Lot / Code Info

All lots within expiry. NDC 0093-7809-56 & NDC 0093-7809-98

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls